시장보고서
상품코드
1441338

세계의 에피제네틱스 시장 규모, 점유율, 성장 분석, 제품 유형별, 기술별, 용도별, 산업별 예측(2023-2030년)

Global Epigenetics Market Size, Share, Growth Analysis, By Product type(Reagents, Kits), By Technology(DNA Methylation, Histone Methylation), By Application(Oncology, Cardiovascular Diseases) - Industry Forecast 2023-2030

발행일: | 리서치사: SkyQuest | 페이지 정보: 영문 157 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 에피제네틱스 시장 규모는 2022년 13억 6,000만 달러로 평가되었습니다. 2023년 16억 달러에서 2031년에는 47억 달러에 달하고, 예측 기간(2024-2031년) 동안 14.8%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계 후성유전학 시장은 유전체 연구의 발전과 후성유전학 메커니즘에 대한 이해도가 높아지면서 최근 세계 후성유전학 산업에서 소비자의 선호도와 니즈가 변화하면서 큰 성장을 보이고 있습니다. 후성유전학은 기본 DNA 서열을 변경하지 않고 유전자 활성을 변화시키는 연구로, 많은 생물학적 과정과 질병에 중요한 역할을 합니다. 신경학, 심장병학, 종양학 및 기타 치료 분야에서의 적용 확대가 시장을 주도하고 있습니다. 후성유전학의 세 가지 주요 연구 분야는 비암호화 RNA 조절, 히스톤 변형, DNA 메틸화입니다. 후성유전학 시장은 표적치료와 맞춤의료에 대한 요구가 증가함에 따라 더욱 성장할 것으로 예상됩니다. 이 분야의 주요 기업들은 최첨단 기술과 솔루션을 제공하기 위해 연구개발에 투자하고 있으며, 이는 세계 후성유전학 시장 전체의 성장과 발전에 기여하고 있습니다.

목차

주요 요약

  • 시장 개요
  • 번영과 쇠퇴

조사 방법

  • 정보 조달
  • 2차/1차 정보원
  • 시장 규모 추정
  • 시장 전제조건과 제한

상위 시장 분석

  • 시장 개요
  • 시장 규모
  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제

주요 시장 인사이트

  • 기술 분석
  • 가격 분석
  • 공급망 분석
  • 밸류체인 분석
  • 시장 생태계
  • IP 분석
  • 무역 분석
  • 스타트업 분석
  • 원재료 분석
  • 혁신 매트릭스
  • 파이프라인 제품 분석
  • 거시경제 지표
  • 주요 투자 분석
  • 주요 성공 요인
  • 경쟁 정도

시장 역학과 전망

  • 시장 역학
    • 성장 촉진요인
    • 기회
    • 성장 억제요인
    • 과제
  • 규제 상황
  • Porter의 Five Forces 분석
  • 향후 혼란에 관한 특별 인사이트

세계의 에피제네틱스 시장 : 제품 유형별

  • 시장 개요
  • 시약
  • 키트
  • 기기
  • 효소
  • 서비스

세계의 에피제네틱스 시장 : 기술별

  • 시장 개요
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • MicroRNA Modification
  • 기타

세계의 에피제네틱스 시장 : 용도별

  • 시장 개요
  • 종양학
  • 심혈관 질환
  • 대사성 질환
  • 신경 질환
  • 면역학

세계의 에피제네틱스 시장 규모 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 스페인
    • 프랑스
    • 영국
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • GCC 국가
    • 남아프리카공화국
    • 기타 중동 및 아프리카

경쟁 구도

  • 주요 5개사 비교
  • 주요 기업의 시장 포지셔닝(2021년)
  • 주요 시장 기업이 채택한 전략
  • 주요 성공 전략
  • 시장에서의 최근 활동
  • 주요 기업의 시장 점유율(2021년)

주요 기업 개요

  • AbbVie Inc.
  • AstraZeneca PLC
  • Bayer AG
  • BeiGene Ltd.
  • Bristol Myers Squibb Company
  • Epizyme, Inc.
  • GlaxoSmithKline PLC
  • Incyte Corporation
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Roche Holding AG
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Targovax, Inc.
  • Vertex Pharmaceuticals Incorporated
  • Vivid Biosciences Inc.
  • Zymeworks Inc.
LSH 24.04.11

Global Epigenetics Market size was valued at USD 1.36 billion in 2022 and is poised to grow from USD 1.6 billion in 2023 to USD 4.7 billion by 2031, growing at a CAGR of 14.8% during the forecast period (2024-2031).

The Global Epigenetics Market is experiencing significant growth due to the advances in genomic research and a greater comprehension of epigenetic mechanisms, leading to changes in consumer preferences and needs in the worldwide epigenetics industry in recent years. Epigenetics is the study of heritable modifications to gene activity without changing the underlying DNA sequence, and it is important for many biological processes and disorders. Growing applications in neurology, cardiology, oncology, and other therapeutic areas are driving the market. Three main areas of study in epigenetics include non-coding RNA regulation, histone modification, and DNA methylation. The market for epigenetics is anticipated to grow further due to the growing need for targeted medicines and personalized medicine. In order to bring cutting-edge technology and solutions, major players in the business are spending in research and development, which helps the overall growth and evolution of the global epigenetics market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Epigenetics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Epigenetics Market Segmental Analysis

There are four main segments in the worldwide Epigenetics Market: product type, technology, application, and region. It is separated into reagents, kits, instruments, enzymes, and services according to kind. It is divided into two categories according to technology: additional epigenetic alterations and microRNA modification, and histone acetylation, DNA methylation, and histone methylation. It is divided into categories according to application, including immunology, neurological disorders, metabolic diseases, cardiovascular diseases, and oncology. The market is divided into North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa based on geographic factors.

Drivers of the Global Epigenetics Market

A major driver in this market is growing understanding of how essential epigenetic mechanisms are for controlling gene expression and affecting a range of biological functions. The demand for epigenetic tools and technologies has increased due to this increased understanding, which has spurred a boom in research activity across the academic, pharmaceutical, and biotechnology sectors. Furthermore, there is a greater emphasis on customized medicine due to the increased prevalence of chronic illnesses like cancer and neurological disorders, where epigenetics is essential in determining the best course of treatment.

Restraints in the Global Epigenetics Market

The high cost of advanced epigenetic technologies is one of the primary market barriers, preventing wider acceptance and accessibility, especially in areas with limited resources. The regulatory hurdles posed by ethical considerations and data privacy issues in epigenetic research have an impact on the rate of innovation. In addition, challenges to a smooth incorporation into clinical practice include the difficulty of interpreting epigenetic data and the absence of standardized analytical techniques..

Market Trends of the Global Epigenetics Market

The growing use of epigenetic insights in customized medicine is propelling the creation of specific treatments for a range of illnesses. Research activities are becoming more precise and efficient as a result of the integration of artificial intelligence and machine learning in the processing of large epigenomic datasets. Furthermore, non-invasive epigenetic diagnostics-which use tools like liquid biopsies to detect diseases like cancer early-are receiving more attention. With the increasing popularity of epigenome editing tools, researchers can now alter particular epigenetic marks, creating new opportunities for therapeutic interventions.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Epigenetics Market by Product type

  • Market Overview
  • Reagents
  • Kits
  • Instruments
  • Enzymes
  • Services

Global Epigenetics Market by Technology

  • Market Overview
  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • MicroRNA Modification
  • and Other Epigenetic Modifications

Global Epigenetics Market by Application

  • Market Overview
  • Oncology
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Neurological Disorders
  • Immunology

Global Epigenetics Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • AbbVie Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BeiGene Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol Myers Squibb Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Epizyme, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline PLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Incyte Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Regeneron Pharmaceuticals, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seattle Genetics, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Targovax, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vertex Pharmaceuticals Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vivid Biosciences Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymeworks Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제